Welcome to This Week in Nephrology. This week we're covering 10 notable papers spanning dialysis decision-making and drug therapy at the extremes of kidney function, biomarkers and biopsy classification that sharpen how we phenotype glomerular diseas…
This week's papers:
1. Outcomes from the International Society of Nephrology Forum on Complement Therapeutics in C3G & IgAN. — Kidney International 2026
2. Diagnosis and management of acute hyperkalaemia. — BMJ 2026
3. Glucagon-Like Peptide-1 Receptor Agonist Use and Risks of Hospitalization and Mortality in Patients with End-Stage Kidney Disease. — Clinical Journal of the American Society of Nephrology 2026
4. Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis. — Journal of the American Society of Nephrology 2026
5. Improving the Histologic Classification of Advanced Diabetic Nephropathy Based on the Transformative Research in Diabetic Nephropathy (TRIDENT) Findings. — Kidney International 2026
6. Evaluating Patterns and Outcomes in the Prescription of Incremental Peritoneal Dialysis in Support of Shared Decision-Making. — Clinical Journal of the American Society of Nephrology 2026
7. Vaccination and Safe Living Strategies for Solid Organ Transplant Candidates and Recipients: Guidelines from the American Society of Transplantation Infectious… — American Journal of Transplantation 2026
8. Serum levels of guanidinylated YB-1 indicate active lupus nephritis. — Nephrology Dialysis Transplantation 2026
9. Performance-Based Frailty Tools Capture Distinct Risk Phenotypes in Kidney Transplant Candidates: A Comparative Analysis of FRAIL and SPPB. — American Journal of Transplantation 2026
10. Plasma Levels of Growth Differentiation Factor 15 and Adverse Kidney Outcomes: Proteomics-Based Mediation Analysis and Mendelian Randomization. — Clinical Journal of the American Society of Nephrology 2026
Listen at https://audioscholar.cc/episode/uemahvbg9y
Podden och tillhörande omslagsbild på den här sidan tillhör
AudioScholar. Innehållet i podden är skapat av AudioScholar och inte av,
eller tillsammans med, Poddtoppen.